J, T., T, H., B, E., U, O., F, L., S, S., & CM, D. (2025). Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments. PharmacoEconomics, 43(10), 1223. https://doi.org/10.1007/s40273-025-01524-w
Chicago Style (17th ed.) CitationJ, Tomeczkowski, Heidbrede T, Eichinger B, Osowski U, Leverkus F, Schmitter S, and Dintsios CM. "Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments." PharmacoEconomics 43, no. 10 (2025): 1223. https://doi.org/10.1007/s40273-025-01524-w.
MLA (9th ed.) CitationJ, Tomeczkowski, et al. "Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology Assessments." PharmacoEconomics, vol. 43, no. 10, 2025, p. 1223, https://doi.org/10.1007/s40273-025-01524-w.